Hap Trading, LLC Dynavax Technologies Corp Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$9.75 - $14.44 $108,663 - $160,933	11,145 Added 55.98%	31,055 $337,000
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $341,313 - $542,681	-25,916 Reduced 56.55%	19,910 $280,000
Q3 2021 Nov 10, 2021	BUY	$9.16 - $19.83 $125,739 - $272,206	13,727 Added 42.76%	45,826 $880,000
Q1 2021 May 14, 2021	SELL	$4.57 - $11.18 $60,369 - $147,687	-13,210 Reduced 29.16%	32,099 $316,000
Q1 2019 May 10, 2019	SELL	$7.08 - $12.09 $349,128 - $596,182	-49,312 Reduced 52.12%	45,309 $331,000
Q4 2018 Feb 12, 2019	BUY	$8.14 - $13.28 $770,214 - $1.26 Million	94,621 New	94,621 $866,000

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.